Moreover, irisin has been shown to ameliorate lipopolysaccharide-induced inflammation in macrophages by MAPK/ERK and PI3K/AKT signaling pathways linked to the pathogenesis of UC and UC-associated colon cancer [55]. Here, FNDC5 is linked to malignant colon neoplasm.